Generic epidemiological differences between extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli (ESBL-EC) and Klebsiella pneumoniae (ESBL-KP), are poorly defined. Nonetheless, defining such differences and understanding their basis ... Infection Control Today, 1 week ago
Urinary tract infections caused by extended-spectrum beta-lactamase-producing bacteria in children: A matched case control study - Abstract - UroToday, 1 month ago
1 images for "esbl"
DISCIPLINARY action taken against a number of staff at University Hospital Galway (UHG) following the death of Savita Halappanavar has been slammed as a "total whitewash". The HSE said the disciplinary action against almost all of the nine staff has ...Irish Independent, 3 days ago
Modification of the protocol for a relatively new test for a dangerous form of antibiotic resistance has been done by researchers from Oregon State Public Health, and increased its specificity to 100 percent. Their research, confirming the ...MedIndia, 6 days ago Researchers modify protocol to test dangerous form of antibiotic resistance News-Medical.Net, 1 week ago Inexpensive lab test identifies resistant infections in hours EurekAlert!, 1 week ago Simple and inexpensive lab test identifies resistant infections in hours Medical News Today, 5 days ago
Actavis confirmed that the US Food and Drug Administration (US FDA) has accepted for filing Actavis' application for ceftazidime-avibactam, its investigational antibiotic for the treatment of patients with Complicated Urinary Tract Infections (cUTI) ...PharmaBiz, 1 week ago FDA accepts Actavis' NDA filing for ceftazidime-avibactam Pharmaceutical Business Review, 6 days ago Actavis Announces FDA Acceptance of the NDA Filing for Ceftazidime-Avibactam, a Qualified Infectious Disease Product Reliance Trust, 1 week ago ACTAVIS : Announces FDA Acceptance of the NDA Filing for Ceftazidime-Avibactam, a Qualified Infectious Disease Product 4 Traders, 1 week ago
by Pascal Cholley, Roughyatou Ka, Christophe Guyeux, Michelle Thouverez, Nathalie Guessennd, Beniam Ghebremedhin, Thierry Frank, Xavier Bertrand, Didier Hocquet Background Pseudomonas aeruginosa ( PA ) has a non-clonal, epidemic population with a ...Plosone.org, 1 week ago
Capillary-Electrophoresis Mass Spectrometry for the Detection of Carbapenemases in (Multi-)Drug-Resistant Gram-Negative Bacteria
In a time in which the spread of multidrug resistant microorganisms is ever increasing, there is a need for fast and unequivocal identification of suspect organisms to supplement existing techniques in the clinical laboratory, especially in single ...Analytical Chemistry, 1 week ago Multidrug-Resistant K. pneumoniae Isolates General Medicine eJournal, 2 weeks ago The global march of antibiotic-resistant bugs Irish Times, 1 month ago Untreatable - 10 dangerous antibiotic-resistant infections New Zealand Herald, 2 months ago
Home » General Business News By PPI News Agency Karachi, September 01, 2014 (PPI-OT): Company Name Turnover Prv.Rate Open Rate Highest Lowest Last Rate Diff. Financial Services AHL Arif Habib Ltd. ...Pakistan Press International, 1 week ago Karachi Stock Exchange Closing Rate of Financial Services dated 22-07-2014 Pakistan Press International, 1 month ago
Cubist Pharmaceuticals, Inc., a biopharmaceutical company, has received the European Medicines Agency, or EMA, acceptance for reviewing its marketing authorization application, or MAA, for its investigational anti-bacterial agent, ...Individual.com, 1 week ago EMA to review Cubist antibiotic Hospital Pharmacy Europe, 2 weeks ago Cubist Gets EMA Acceptance for Review of MAA for Ceftolozane/Tazobactam Individual.com, 2 weeks ago Cubist Highlights EMA Acceptance of Ceftolozane/Tazobactam Marketing Authorization Application for Review Individual.com, 2 weeks ago
More from: Reuters, Stock Nod...and 41 other sources
By , associate editor NICE Gives Nod Of Approval To Celgene's Revlimid NICE has published final draft guidance stating that Celgene's Revlimid for myelodysplastic syndromes will be available on the NHS in England. The recommendation applied to ...Pharmaceutical Online, 2 weeks ago
Allergan Receives Written Requests from Pershing Square; Cubist Announces EMA Acceptance of Ceftolozane/Tazobactam Marketing
Below is a look at some of the headlines for companies that made news in the healthcare sector on August 22, 2014. Allergan, Inc. (NYSE: AGN) confirmed that Pershing Square Capital Management, L.P. (Pershing Square) has delivered written ...BioMedReports, 3 weeks ago
on your WebpageAdd Widget >Get your members hooked!